Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Wearable Injectors Companies

Wearable injectors companies specialize in the development and manufacturing of innovative medical devices designed to administer injectable medications in a convenient, patient-friendly, and wearable manner. These devices are often used for the self-administration of biologics, insulin, growth hormones, and other injectable drugs.

Latest Wearable Injectors Companies Update

Nov 2023:Eli Lilly and Company's ZepboundTM (tirzepatide) injectable was accepted by the U.S. Food and Drug Administration (FDA). This is the first and only obesity medication that stimulates GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) hormone receptors. Adults who are overweight (BMI of 27 kg/m2 or higher), obese (BMI of 30 kg/m2 or higher), or who have weight-related medical conditions (hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, cardiovascular disease) may benefit from using Zepbound to help them lose weight and keep it off. It should be combined with a diet that is low in calories and more exercise. Zepbound has not been evaluated in patients with a history of pancreatitis or severe gastrointestinal disorders, such as severe gastroparesis. It should also not be used with other products containing tirzepatide or GLP-1 receptor agonist medications.

Jan 2023: CeQur Simplicity, a Swiss manufacturer of medical devices, is to invest $20 million to start production in Lexington County. To bring the manufacture of its diabetic insulin patch to South Carolina, the company is entering into a deal with Flex, a multinational manufacturing corporation with its headquarters in Singapore and an industrial park in Lexington County close to Columbia Metropolitan Airport. From Boston to Greenville, the firm moved its North American headquarters. Flex is moving its R&D and manufacturing operations to its West Columbia plant from its Tijuana, Mexico, location. At the meeting on February 8, Lexington County Council is considering reducing property taxes for manufacturers from 10 percent to 6 percent as compensation for CeQur's investment.

List of Wearable Injectors Key companies in the market

West Pharmaceutical Services, Inc.

Valeritas, Inc.

Eli Lilly and Company

YPSOMED

Amgen Inc.

Becton, Dickinson and Company (BD)

CeQur SA

SteadyMed Therapeutics, Inc.

BioSpace

Enable Injections

Sensile Medical AG

Wearable Injectors Market Highlights:

Wearable Injectors Market Size

Wearable Injectors Market Trends

Wearable Injectors Market Analysis

Wearable Injectors Market Share

Wearable Injectors Market Highlights:

Wearable Injectors Market Trends

Wearable Injectors Market Analysis

Wearable Injectors Market Share

Wearable Injectors Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.